Presented by Irina Stepanov, PhD
Division of Environmental Health Sciences
Over the past decades, the public health community has made significant achievements in reducing the overall prevalence of smoking in the US. However, this progress has not been uniform across various populations, and high prevalence of tobacco use in some subgroups is accompanied by elevated risk of related diseases and other disparities. Furthermore, the diversity of products designed for tobacco and nicotine intake expanded remarkably over the past decade. The current marketplace offers products that appeal to various groups of consumers and range widely in their toxic and carcinogenic potential. Dr. Stepanov will discuss the application of analytical biochemistry tools for characterizing tobacco product diversity, identifying individuals and populations at risk for disease, risk communication, and tobacco product regulation.
All faculty, staff, and students welcome! Light refreshments will be served.